China NMPA Drug Inspection - Bozhou Jingwan Traditional Chinese Medicine Pieces Factory, China - persimmon calyx
China NMPA drug inspection for Bozhou Jingwan Traditional Chinese Medicine Pieces Factory, China published December 14, 2017. Drug: persimmon calyx. On December 14, 2017, Fujian Province's drug regulatory departments, under the National Medical Products Administration
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Bozhou Jingwan Traditional Chinese Medicine Pieces Factory, China published December 14, 2017. Drug: persimmon calyx. On December 14, 2017, Fujian Province's drug regulatory departments, under the National Medical Products Administration
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox